{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:39:28Z","timestamp":1783006768648,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,30]]},"DOI":"10.7759\/cureus.57289","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T01:24:16Z","timestamp":1711848256000},"source":"Crossref","is-referenced-by-count":1,"title":["Cochleovestibular Signs As the First Manifestation of Fabry Disease: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Yasmina","family":"Zakaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naji","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib","family":"Kissani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"A-galactosidase a deficiency: Fabry disease","author":"Desnick RJ","year":"2019","unstructured":"Desnick RJ, Ioannou YA, Eng CM. A-galactosidase a deficiency: Fabry disease. The online metabolic and Molecular Bases of Inherited Disease. Valle DL, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA (ed): McGraw-Hill Education, New York, US; 2019."},{"key":"ref2","article-title":"Gastrointestinal manifestations of Fabry disease","author":"Keshav S","year":"2006","unstructured":"Keshav S. Gastrointestinal manifestations of Fabry disease. Fabry disease: perspectives from 5 years of FOS. Mehta A, Beck M, Sunder-Plassmann G (ed): Oxford PharmaGenesis, Oxford; 2006."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot KD","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001, 38:750-60. 10.1136\/jmg.38.11.750","journal-title":"J Med Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-3-10","article-title":"Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients","volume":"3","author":"Germain DP","year":"2002","unstructured":"Germain DP, Avan P, Chassaing A, Bonfils P. Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet. 2002, 3:10. 10.1186\/1471-2350-3-10","journal-title":"BMC Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2006.01702.x","article-title":"Hearing loss in Fabry disease: data from the Fabry Outcome Survey","volume":"36","author":"Hegemann S","year":"2006","unstructured":"Hegemann S, Hajioff D, Conti G, et al.. Hearing loss in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest. 2006, 36:654-62. 10.1111\/j.1365-2362.2006.01702.x","journal-title":"Eur J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-007-0575-y","article-title":"Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy","volume":"254","author":"Palla A","year":"2007","unstructured":"Palla A, Hegemann S, Widmer U, Straumann D. Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy. J Neurol. 2007, 254:1433-42. 10.1007\/s00415-007-0575-y","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225071","article-title":"Significant hearing loss in Fabry disease: study of the Danish nationwide cohort prior to treatment","volume":"14","author":"Yazdanfard PD","year":"2019","unstructured":"Yazdanfard PD, Madsen CV, Nielsen LH, et al.. Significant hearing loss in Fabry disease: study of the Danish nationwide cohort prior to treatment. PLoS One. 2019, 14:0225071. 10.1371\/journal.pone.0225071","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta A","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, et al.. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004, 34:236-42. 10.1111\/j.1365-2362.2004.01309.x","journal-title":"Eur J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada M","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, et al.. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006, 79:31-40. 10.1086\/504601","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry registry","volume":"30","author":"Eng CM","year":"2007","unstructured":"Eng CM, Fletcher J, Wilcox WR, et al.. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry registry. J Inherit Metab Dis. 2007, 30:184-92. 10.1007\/s10545-007-0521-2","journal-title":"J Inherit Metab Dis"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/13.7.565","article-title":"Enzymatic abnormalities in diseases of sphingolipid metabolism","volume":"13","author":"Brady RO","year":"1967","unstructured":"Brady RO. Enzymatic abnormalities in diseases of sphingolipid metabolism. Clin Chem. 1967, 13:565-77.","journal-title":"Clin Chem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.55","article-title":"Is it Fabry disease?","volume":"18","author":"Schiffmann R","year":"2016","unstructured":"Schiffmann R, Fuller M, Clarke LA, Aerts JM. Is it Fabry disease?. Genet Med. 2016, 18:1181-5. 10.1038\/gim.2016.55","journal-title":"Genet Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101857","article-title":"A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance","volume":"51","author":"van der Tol L","year":"2014","unstructured":"van der Tol L, Smid BE, Poorthuis BJ, Biegstraaten M, Deprez RH, Linthorst GE, Hollak CE. A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet. 2014, 51:1-9. 10.1136\/jmedgenet-2013-101857","journal-title":"J Med Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid BE","year":"2014","unstructured":"Smid BE, van der Tol L, Cecchi F, et al.. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. Int J Cardiol. 2014, 177:400-8. 10.1016\/j.ijcard.2014.09.001","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-013-9613-3","article-title":"Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors","volume":"22","author":"Laney DA","year":"2013","unstructured":"Laney DA, Bennett RL, Clarke V, et al.. Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2013, 22:555-64. 10.1007\/s10897-013-9613-3","journal-title":"J Genet Couns"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke JT","year":"2007","unstructured":"Clarke JT. Narrative review: Fabry disease. Ann Intern Med. 2007, 146:425-33. 10.7326\/0003-4819-146-6-200703200-00007","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq073","article-title":"Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women","volume":"12","author":"Havndrup O","year":"2010","unstructured":"Havndrup O, Christiansen M, Stoevring B, et al.. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail. 2010, 12:535-40. 10.1093\/eurjhf\/hfq073","journal-title":"Eur J Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/gim.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang RY","year":"2007","unstructured":"Wang RY, Lelis A, Mirocha J, Wilcox WR. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med. 2007, 9:34-45. 10.1097\/gim.0b013e31802d8321","journal-title":"Genet Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0523-0","article-title":"Hearing loss in a family affected by Fabry disease","volume":"30","author":"Sergi B","year":"2007","unstructured":"Sergi B, Conti G. Hearing loss in a family affected by Fabry disease. J Inherit Metab Dis. 2007, 30:370-4. 10.1007\/s10545-007-0523-0","journal-title":"J Inherit Metab Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate YA","year":"2008","unstructured":"Zarate YA, Hopkin RJ. Fabry's disease. Lancet. 2008, 372:1427-35. 10.1016\/S0140-6736(08)61589-5","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/241088-cochleovestibular-signs-as-the-first-manifestation-of-fabry-disease-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T01:24:21Z","timestamp":1711848261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/241088-cochleovestibular-signs-as-the-first-manifestation-of-fabry-disease-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.57289","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,30]]}}}